Biomarkers for cancer sensitivity and uses thereof

Details Biomarkers for cancer sensitivity and uses thereof Biomarkers for cancer sensitivity and uses thereof

G - Physics

01

N

G01N 33/574 (2006.01) G01N 33/50 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2666484

Disclosed herein are fructose-biphosphate aldolase a (ALDOA), phosphoglycerate kinase 1 (PGKl), peroxiredoxin 1 (PRDX 1), cof ilin 1 and histone H4 as biomarkers for evaluating anti-cancer agent efficacy and for predicting cancer cell sensitivity.

L'invention concerne des biomarqueurs et des utilisations de ceux-ci permettant d'évaluer une efficacité anti-cancéreuse et une sensibilité au cancer.

Affiliated with

Also associated with

Rating

Biomarkers for cancer sensitivity and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for cancer sensitivity and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for cancer sensitivity and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1878393